Nicotine / THR - Statements from Experts

From Safer nicotine wiki
Jump to navigation Jump to search
A picture of scientific notes, chemical formula with the words "THR Statements from Experts. Statements: Medical Professionals, Scientists, Tobacco Control etc"
Statements From Experts


Scientists, Professors, Medical Professionals, Tobacco Control and Public Health Leaders, along with Lawmakers and Investigative Journalists are speaking out in support of adult use of Tobacco Harm Reduction (THR) products to help people quit smoking and to prevent relapse.



Afghanistan

Attaullah Ahmadi

  • notes from an email
  • Attaullah Ahmadi is a Medical Doctor from Afghanistan. He is currently pursuing his MPH with a focus on Epidemiology and Biostatistics at the École des Hautes Études en Santé Publique (EHESP) in France Attaullah Ahmadi is the senior advisor to Global Health Focus (GHF), a network of academics and researchers who seek to achieve health for all. He is also a member at Youth Editorial Board of Public Health Challenges (a Wiley journal). He has served as the GHF Director of Research for Asia and also as a Research Associate at the Medical Research Center of Kateb University. Attaullah Ahmadi seeks to address health inequities and has published many scientific papers on various health topics in developing countries including Afghanistan, analyzing their health systems and highlighting the challenges they face.


Argentina

Dra. Marta Angueira, Cardiologist

  • Source
  • "Cigarettes have the serious problem that in addition to nicotine, the smoke contains a lot of carcinogens, it contains carbon monoxide, ammonia, this means that what is really very harmful is precisely the smoke. The idea is that these people who are in these conditions, propose that they start using a substitute for cigarettes with the condition that it does less damage, for that there are the chewing gums that have been used for a long time, the patches, there are nasal sprays that contain only nicotine. Electronic cigarettes are another alternative since it is 95% less harmful than the combustion cigarette".



Dr. Guillermo Eduardo Harvey

Oncological Surgeon. Professor of the first chair of Surgery UNNE. Member of the Argentine Academy of Medicine.



Silvia Inchaurraga. PHD.

psychologist. Director of the Center for Advanced Studies on drug addiction and AIDS at the National University of Rosario.



Milton Klun

Pharmacist, Universidad Nacional del Sur.



Dr. Diego Verrastro


Argentina Dr. Diego Verrastro "Quitting smoking can be hard. Vaping is one more way to quit smoking by getting nicotine with fewer toxins that come from the combustion of tobacco. You can be social, spend less, and once you quit, you'll feel better about it"
Argentina Dr. Diego Verrastro


Australia

Professor Amanda Baker

Quote Source / Photo and Bio


Professor Billie Bonevski

Source of neame

Associate Professor Yvonne Bonomo

Source of neame

Ron Borland PhD

Quote Source / Bio and Photo

Ron Borland PhD "The good intentions of many in tobacco control of trying to limit low toxin alternatives to smoking are in all likelihood paving the way to the hell of prolonging the epidemic of smoking- caused harm."
Ron Borland PhD


Stephen Bright, PhD

Photo and Bio / Quote Source / Follow on Twitter


Associate Professor Matthew Browne

Source of name

Dr Andrew Byrne

Photo and Bio / Source: Letter Signatory


Professor David Castle

Photo and Bio / Quote Source


Professor Kate Conigrave

Photo and Bio / Follow on Twitter / Quote 1 Source and Quote 2 Source


Dr Jon Cook

Source of name

Dr Karen Counter

Source of name

Professor Nick Crofts AM

Source of name

Professor Richard (Ric) Day AM

Source of name

Professor Paul Dietze

Source of name

Professor Kate Dolan

Source of name

Professor Adrian Dunlop

Source of name

Conjoint Associate Professor Nadine Ezard

Source of name

Coral Gartner, PhD

Coral Gartner, PhD, School of Public Health Faculty of Medicine Queensland University: "Banning non-therapeutic nicotine vaping products is ethically problematic, because it denies addicted smokers access to a less harmful alternative product and an additional means of quitting smoking."
Coral Gartner, PhD


Professor Charles Gilks

Source of name

Rohan Glasgow

Source of name

Dr Robert Graham

Source of name

Dr Ashleigh Guillaumier

Photo and Bio / Quote Source / Follow on Twitter


Wayne Hall, PHD

Quote Source / Bio and Photo

Wayne Hall PhD "A MORE BALANCED AND SENSIBLE PUBLIC HEALTH POLICY WOULD ALLOW [PEOPLE WHO SMOKE] TO ACCESS E-CIGARETTES IN WAYS THAT MINIMISE YOUTH UPTAKE AND MAXIMISE THE POTENTIAL FOR E-CIGARETTES TO ELIMINATE THE GLOBAL USE OF TOBACCO PRODUCTS"
Wayne Hall PhD


Dr David Helliwell

Source of name

Senator Hollie Hughes

Follow on Twitter

Dr William Huang

Source of name

Dr David Jacka

Source of name

Adjunct Associate Professor Michael Keane

Source of name

Dr Joe Kosterich

Source of name

Rebecca Lang

Source of name

Nicole Lee, PhD

Follow on Twitter / Quote Source / Bio

Nicole Lee, PhD Adjunct Professor, National Drug Research Institute Director, 360Edge: "The question is HOW they are regulated. ‘Regulation’ through prescription is not working and has enhanced the massive black market. If a policy is broken we need to fix it. I don’t have a bias, I have a strong view based on the evidence. I’m not pro vaping. I’m pro harm reduction."
Nicole Lee, PhD Adjunct Professor, National Drug Research Institute Director, 360Edge


Professor Nicholas Lintzeris

Source of name

Dr Michael Lowy

Source of name

Dr Brad Mackay

Follow on Twitter / Quote Source / Bio


Dr Annie Madden AO

Source of name

Professor Lisa Maher AM

Source of name

Associate Professor Victoria Manning

Source of name

Dr Kristen McCarter

Photo and Bio / Quote Source / Follow on Twitter


Associate Professor Mike McDonough

Source of name

Colin Mendelsohn, MB BS

Source: Bio, Photo, and Quote / Follow on Twitter

Dr Colin Mendelsohn "Vaping can be used as a short term quitting aid or as a long-term strategy to avoid going back to smoking and is at least 95% safer than smoking"
Dr Colin Mendelsohn


Dr David Outridge

Source of name

Dr Peter Parry

Source of name

Fiona Patten MP

Follow on Twitter

Mr Garth Popple

Source of name

Evert Rauwendaal

Source of name

Professor Robyn Richmond

Source of name

Professor Alison Ritter AO FASSA

Source of name

Dr Fares Samara

Source of name

Professor Julian Savulescu

Source of name

Dr Catherine Silsbury

Source of name

Kathryn Steadman, PhD

Photo and Bio / Quote Source

Kathryn Steadman, PhD, Associate Professor, School of Pharmacy, Faculty of Health and Behavioural Sciences, The University of Queensland: "The greater barriers to accessing NVPs [nicotine vapor products] than cigarettes are a strong disincentive to switching from cigarettes to NVPs."
Kathryn Steadman, PhD, Associate Professor, School of Pharmacy, Faculty of Health and Behavioural Sciences, The University of Queensland


Dr Penelope Truman

Source of name

Dr Ingrid van Beek AM

Source of name

Dr Thomas Vandeleur

Source of name

Gino Vumbaca OAM

Source of name

Dr Brian Walker MLC

Quote Source / Follow on Twitter

Dr Brian Walker "1. Cigs have NOT been beaten YET. 2. Vaping has been proven to help reduce smoking. 3. Banning vapes is an excellent way of preventing smoking cessation success"
Dr Brian Walker


Judith Watt

Former Executive Director, NCD Alliance - Former Director, Quit Victoria, Source of name, need to find their own quote

Professor Ian Webster AO

Source of name

Ian Webster AO

Source of name

Dr Megan Weir

Source of name

Associate Professor Martin Weltman

Source of name

Associate Professor Scott Wilson

Source of name

Dr. Alex Wodak AM

Quote Source / Bio and Photo / Follow on Twitter

Dr Alex Wodak AM "Opposition to reduced risk nicotine options inevitably protects the smoking of tobacco which is responsible for the deaths of over half of long term smokers. Vaping is now not only the world's most popular stop smoking aid, but the most effective"
Dr Alex Wodak AM


Austria

Ernest Groman, MD


Ernest Groman MD "The data show the abstinence approach is inadequate. The soulution for smokers is to switch to less harmful alternatives"
Ernest Groman MD


Professor Michael Kunze, MD


Professor Michael Kunze, MD, Medical University Vienna, Center for Public Health: "One has to acknowledge, nicotine is a very widely used psychoactive drug, and itself not very harmful to human health as far as the risk for cardiovascular diseases or cancer is concerned. One additional issue for the future would be a need to provide nicotine in the most harmless way to people who do not want or cannot yet stop smoking. "
Professor Michael Kunze, MD, Medical University Vienna, Center for Public Health


Bernhard-Michael Mayer, PhD

Professor of Pharmacology and Toxicology Institute of Pharmaceutical Sciences Karl-Franzens-Universität Graz Austria


Bangladesh

Dr Altamash Mahmood

Belgium

Karolien Adriaens, PhD


Karolien Adriaens PhD Faculty of Psychology and Educational Sciences, KU Leuven, Belgium "Banning flavoured e-cigarettes will discourage smokers from switching, witch leads to the unintended consequences of continuous and prolonged smoking"
Karolien Adriaens


Frank Baeyens, PhD


Frank Baeyens PhD Professor of Psychology, KU Leuven Belgium "Vaping is significantly less harmful than smoking" "E-cigarettes are a valuble tool for many smokers to help them quit smoking" "Regular vaping in non smokeres is rare and there is no evidence of a 'gateway effect' from vaping to smoking" "WHO's stance on THR is anti scientific, morally reprehensible and diametrically opposed to it's primary mission: it costs lives rather than saving them"
Frank Baeyens


Brazil

Silvia Cazenave. PHD.

PHD in Toxicology and Master in Toxicological Analysis.



Monica Gorgulho

Clinical psychology. Masters in Social Psychology. University of São Paulo, Brazil. Harm Reduction Specialist.



Canada

Michael Chaiton



Patrick Fafard, PhD

Full Professor Centre for Health Law, Policy, and Ethics Graduate School of Public and International Affairs University of Ottawa



Kellie Ann Forbes BScN


Kellie Ann Forbes, BScN, Founding member of VAEP: "I am satisfied that vaping is not only exceedingly less harmful than smoking but it is an appealing alternative to current smokers and is preventing future smokers."
Kellie Ann Forbes, BScN, Founding member of VAEP


Amelia Howard, Sociologist



Ian Irvine, PhD


Ian Irvine PhD Professor of Economics at Concordia University, research fellow at the C.D. Howe Institute "The federal government is currently proposing to place very severe restrictions on the vaping market in the form of nicotine content limits and flavour bans. It should be wary of killing the cigarette extinguishing golden goose."
Ian Irvine PhD


Martin Juneau MPs, MD, FRCP(C)


Martin Juneau MPs, MD, FRCP(C) "In recent years electronic cigarettes have emerged as a valid alternative to tobacco cigarettes to reduce the harmful effects of smoking on health."
Martin Juneau MPs, MD, FRCP(C)


Chris Lalonde, PhD


Chris Lalonde PhD "To the extent that you make vaping less accessible, less affordable, then you're going to prevent the very people who are the most likely to benefit from it from accessing it. What kind of government and what kind of science, would support that? It turns out we're living it."
Chris Lalonde PhD


Clifford Garfield Mahood, O.C.

Founding Executive Director (1976-2012) Non-Smokers’ Rights Association Toronto Canada



Dr John Oyston



James (Jim) Rankin

Source of name

David Sweanor, JD

Quote Source / Bio and Photo

David Sweanor JD, Policy and Ethics Ajdunct Proffesor, Faculty of Law, University of Ottawa "Ensuring that a range of low-risk alternatives are not only on the market but have regulatory and tax advantages over cigarettes has the potential to transform public health. We have long known people smoke for nicotine but die from the smoke. Cigarette smoking is a public health catastrophe that can be massively reduced through science and technology if policies can be oriented toward replacing rather than protecting the cigarette business"
David Sweanor JD


Neda Debassige Toeg, BSP, RPh


Neda Debassige Toeg, BSP, RPh, President Aboriginal Pharmacists Association of Canada: "My concern is that harm reduction tools and awareness about alternatives to cigarette use are not available to First Nations" "When given the option to reduce the incidences of smoking , I believe we can substantially reduce overall health risks to First Nations – especially at a time when our people are more vulnerable to harm than the majority of non-First Nations"
Neda Debassige Toeg BSP RPh, President Aboriginal Pharmacists Association of Canada


Mark Tyndall MD ScD FRCPC


Mark Tyndall, Founder of My Safe Society “Around 2012 I heard about vaping. This was the very definition of harm reduction: taking an inherently risky activity and making it way less risky. … The amazing thing about vaping was that for many people, it was even more attractive and satisfying than cigarettes.” “Yet eight years later, who would have thought that throwing a lifeline to people who smoke cigarettes would be so contentious? It should have been a slam-dunk. By now, leading public health authorities around the world should have launched global campaigns to rid the world of cigarettes through vaping. But that just hasn’t happened.”
Mark Tyndall, Founder of My Safe Society


Chile

Hernán Prat Martorell, MD, PhD

Professor at the University of Chile. Former Director of the Cardiovascular Department of the Clinical Hospital of the University of Chile. Former president of the Chilean Society of Hypertension.



Alejandro Erices Ocampo. PHD

Biochemist – Doctor of Science – Post-doctorate in Neurosciences.



Daniel Kleiman Priewer. MD.

Specialist in Traumatology - Orthopedics. Sports injuries. Joint Preservation and Osteoarthritis.



Colombia

Dr. Ramon Calderon

Brazil, Colombia, Spain and Mexico - Doctor in medicine. Plastic Surgeon



Dr. Ana Maria Diaz

PhD in Bioethics.



Hugo Caballero Durán, MD

Former president of the Colombian Society of Pneumology. Former Clinical Scientific Director of Marly Clinic. Director of the Pneumology and Respiratory Therapy Service, Marly Clinic Bogotá, Colombia



Costa Rica

Dr. Randall Rodríguez Obando.

Doctor in medicine. Specialist in Harm Reduction in patients with HIV.



Czech Republic

Pavel Bém MD

Member of the Global Commission on Drug Policy Head of the Clinical Department, Adictology Clinic, Charles University Former Mayor of Prague Member of The National Drug Commission Office of the Government of the Czech Republic


Eva Králíková, MD

Professor Institute of Hygiene and Epidemiology Centre for Tobacco-Dependence First Faculty of Medicine and General Hospital Charles University Prague Czech Republic


Democratic Republic of the Congo

Samuel Mukandi, BA


Samuel Mukandi, BA, Managing Director, Tradelines Group. Chairman Of The Board, Tobacco Harm Reduction DRC: "Vapor technology is one of the most significant public health innovations of the century, and to conflate it with deadly Tobacco products is entirely inappropriate and irresponsible."
Samuel Mukandi, BA, Managing Director, Tradelines Group. Chairman Of The Board, Tobacco Harm Reduction DRC


Ecuador

Dr. Pablo Gallo

Ecuador and Spain - Doctor of Medicine and vascular surgeon specialized in the study and treatment of both arterial pathology and venous pathology and, above all, pelvic venous pathology



César Paz y Miño, MD, PhD

Director, Centro de Investigacion Genética y Genómica and Specialist in Genetics and Human Molecular Biology Universidad UTE Quito, Ecuador



Tanya Soria. MD.

Clinical Oncologist.



Enrique Teran, MD, PhD

Professor College of Health Sciences - Universidad San Francisco de Quito. Ecuadorian Academy of Medicine Academy of Science of Ecuador Ecuador



Francisco E. Urrestra. MD.

Medical Director Hospital Clinica Metropolitana. Ibarra.



El Salvador

Dr. Edward Wollants

Internist and nutritionist.



England/(UK)

Adam Afriyie, BSc


Adam Afriyie, BSc, Chair of Parliamentary Office Science and Technology "Around 50% Medical Practitioners didn't know smoking was more harmful than vaping"
Adam Afriyie, BSc, Chair of Parliamentary Office Science and Technology


Sanjay Agrawal, MD, MBChB


Sanjay Agrawal MD, Professor of Respiratory medicine University Leicester, Chair of Royal Collage Physicians Tobacco Advisory Group: "We want to make e-cigarettes attractive to smokers who are trying to quit. That's the point. For many people, adding flavours, and taking away the taste of tobacco is quite helpful"
Sanjay Agrawal MD, Professor of Respiratory medicine University Leicester, Chair of Royal Collage Physicians Tobacco Advisory Group


Deborah Arnott


Deborah Arnott, MBA, CEO ASH-UK “There are people in the public health community who are obsessed by e-cigarettes” "That because there is so much bad publicity about them, people’s understanding about the relative risk of smoking and e-cigarettes is being undermined. The risk is that smokers who could potentially use these as an alternative to smoking are being discouraged, and that’s not a good thing.” "Do you want the tobacco industry to carry on making cigarettes which are highly addictive and kill when used as intended, or do you want them to move to a product which is much nearer licensed nicotine replacement therapy and is unlikely to kill anyone?”
Deborah Arnott, MBA, CEO ASH-UK


Prof Paul Aveyard


Paul Aveyard, PhD FRCP FRCGP FFPH PROFESSOR OF BEHAVIOURAL MEDICINE Nuffield Department of Primary Care Health Sciences: "Within a few years, the e-cigarette has taken off and meant that people are using it to stop, or reduce, their smoking in huge numbers. Insofar as you can tell from the data we have, this would appear to be an effective thing to do."
Paul Aveyard, PhD FRCP FRCGP FFPH PROFESSOR OF BEHAVIOURAL MEDICINE Nuffield Department of Primary Care Health Sciences


Clive Bates

Quote Source / Bio and Photo / Follow on Twitter


Emma V Beard



John Britton, MD

Quote Source / Bio and Photo

John Britton, MD, Director UK Center For Tobacco and Alcohol Studies, Professor of Epidemiology University Nottingham "Health policy should be driven by science, not prejudice or dogma. Vaping has already provided an effective gateway out of smoking for millions of people, unequivocally benefiting individual smokers, public health and wider society."
John Britton, MD, Director UK Center For Tobacco and Alcohol Studies, Professor of Epidemiology University Nottingham


Leonie Brose, PhD



George Butterworth, BSc


George Butterworth, BSc Policy Manager Cancer Research UK 2014-2022: "...vaping is less harmful than smoking tobacco and can help people to stop smoking..."
George Butterworth, BSc Policy Manager Cancer Research UK 2014-2022


Carolina Garcia Canton

  • Disclosure: BAT


Hazel Cheeseman, MSc


Hazel Cheeseman, MSc. Deputy Chief Executive, Action on Smoking and Health (ASH UK): "Wait. What? I'm almost speechless. Parents [in Australia] seek to replace vaping with the more addictive much much more lethal alternative... smoking. How does this level of misunderstanding come about and how can we guard against it here in the UK?"
Hazel Cheeseman, MSc. Deputy Chief Executive, Action on Smoking and Health (ASH UK).


Sharon Cox, PhD



David Crane PhD


David Crane PhD: "There is no good evidence that vaping makes addicts out of people who would not otherwise become so but substantial good evidence that it helps smokers quit. The public health benefits for which are huge."
David Crane PhD


Lynne Dawkins, PhD

  • Quote Source / Bio and Photo / Follow on Twitter
  • Disclosures: I have provided consultancy for the pharmaceutical industry relating to the development of smoking cessation products. I have no conflicts with respect to the tobacco or e-cigarette industry.



Martin Dockrell




Katherine "Katie" East, PhD

Quote and Graphic / Follow on Twitter / Bio


Dr Matthew Evison



Jonathan Fell



Floe Foxon, BSc



Suzi Gage



Stuart Griffiths, PhD


Stuart Griffiths, PhD, Director of Research, Services, and Policy, Yorkshire Cancer Research: "When it comes to helping people quit for good, being able to offer vaping products is essential. They are an incredibly effective aid in helping people give up cigarettes.”
Stuart Griffiths, PhD, Director of Research, Services, and Policy, Yorkshire Cancer Research


Peter Hajek, PhD



David Halpern, PhD


David Halpern, PhD, CEO - Behavioural Insights Team: "...we should deliberately seek to make e-cigs widely available, and to use regulation not to ban them but to improve their quality and reliability."
David Halpern, PhD, CEO - Behavioural Insights Team


Jamie Hartmann-Boyce


Dr Richard Holliday

Photo and Quote Source / Follow on Twitter

Benjamin Human

Source of name

Sarah Jackson, PhD, MSc



Martin Jarvis ODE, PhD

Quote Source / Bio and Photo


Mark Jenkinson MP



Patricia Kovacevic, JD



Sir Norman Lamb

Graphics Source / Follow on Twitter


Rosemary Leonard, MBE, MA, MB, BChir, MRCGP, DRCOG

Quote Source / Bio / Follow on Twitter


Nicola Lindson


Martin Machray

Professor Stefan Marciniak

"Current evidence supports vaping as a safer option than smoking, so a switch is better than not switching."

Olivia M Maynard, PhD

Senior Lecturer, School of Psychological Science Bristol Population Health Science Institute MRC Integrative Epidemiology Unit Bristol, United Kingdom


Professor Elaine McColl

Dr Andy McEwen

  • National Centre of Smoking Cessation and Training, Dorchester, UK


Jim McManus, OCDS, FFPH


Jim McManus, OCDS, FFPH President, The Association of Directors of Public Health (UK): "But it seems to me that we have enough of an accumulation of evidence that e-cigarettes are so much safer than tobacco cigarettes, even if we only discuss the levels of emissions of chemicals, that not working with e-cigarettes is to expose people to potentially avoidable harm, and that this is unethical. I feel ethically compelled to find a way of working with e-cigarettes as a public health tool. And the fact that some public health debate has made people – wrongly as the consensus statement says – feel e-cigarettes may even be more harmful than tobacco is something we ought to find shocking and chilling."
Jim McManus, OCDS, FFPH President, The Association of Directors of Public Health (UK)


Ann McNeill, PhD



Dr Peter Miller

  • Chief Executive of Leicestershire Partnership Trust
  • Quote Source
  • “We understand that stopping smoking can cause discomfort, and have put in place a number of initiatives to support people to not smoke while on our premises, or ideally give up for good. This includes the provision of nicotine replacement therapy and, if required, products for vaping. Whilst we are not there yet, we are committed to continuing on this journey to be smokefree


Marcus Munafò, PhD

Professor of Biological Psychology and MRC Investigator MRC Integrative Epidemiology Unit School of Psychological Science University of Bristol United Kingdom


Dr Kevin Murphy


John Newton, FRCP FFPH FRSPH

Quote Source / Bio


Caitlin Notley, PhD



David Nutt DM, FRCP, FRCPsych, FSB, FMedSci

Quote Source / Bio and Photo / Follow on Twitter


Dr Kirstie Soar

  • Centre of Addictive Behaviours Research, London South Bank University, UK


Dr. Sudhanshu Patwardhan

Snus Forum Interview

Debbie Robson, PhD



Louise Ross



Dr Kathryn Scott

  • Quote Source
  • chief executive at Yorkshire Cancer Research
  • "Easy and reliable access to vaping products will give more people in Yorkshire the best chance of quitting for good.”


Lion Shahab, PhD CPsychol AFBPsS

  • Quote Source / Bio / Photo / Follow on Twitter
  • Disclosures: LS has received a research grant, honoraria for talks, consultancy and travel expenses to attend meetings and workshops from pharmaceutical companies that make smoking cessation products (Pfizer; Johnson & Johnson). He has never received any funding or other monetary benefits from the tobacco or e-cigarette industry.



Erikas Simonavičius, PhD


Professor Gerry Stimson

  • Follow on Twitter / Quote Source
  • In almost all areas of public health, affected communities are now seen as a vital part of the policymaking process and the same recognition is long overdue in this field. Policymakers need to hear the experiences of people who have switched away from smoking, and take note of how their decisions are likely to impact people’s lives.


Harry Tattan-Birch, MSc

Bio

Eve Taylor

Quote Source

Frances Thirlway, PhD, MSc



Dr Russell Thorpe

Quote source

Robert West, PhD

Professor Emeritus in Health Psychology, University College London


France

Marion Adler, PhD

Smoking Cessation Specialist Hôpital Antoine Béclère Clamart France


Philippe Arvers, MD, PhD

Tobaccologist ans addictologist Université Grenoble Alpes France


Élisabeth Borne, Prime Minister



Professor Bertrand Dautzenberg



Julien Didry



Jacques Le Houezec, PhD



Olivier Véran



Germany

Peter Liese MEP

Tweet about Peter

Alexander K. Nussbaum, PhD



Dr Ingo Schröder



Dr. F. Artur Schroers



Frank Sitta

tweet about Frank

PROFESSOR HEINO STÖVER



Prof. Dirk Ziebolz



Greece

Konstantinos Farsalinos, MD, MPH

Quote Source / Bio and Photo / Follow on Twitter


Guatemala

Dr Erick Estrada

Family doctor and surgeon. Focused on preventive medicine



Iceland

G. Karl Snæbjörnsson, MD



India

Dr Nimesh Desai



Aparajeet Kar, MD

Consultant Pulmonology and Critical Care Sir H.N Reliance Foundation Hospital Mumbai India


Dr Kiran Melkote, MBBS, MS



Rohan Sequeira, MD, PhD


Rohan Sequeira, MD, PhD "Medical professionals need to realise that switching patients who smoke to a healthier alternative like Vaping is the next best thing to smoke cessation, which by itself is a very difficult task. Regulate not Ban."
Rohan Sequeira, MD, PhD


Ireland

Dr Garrett McGovern



Italy

Pietro Fiocchi

Follow on Twitter / Tweet with info / Quote:


Riccardo Polosa



Umberto Tirelli MD

Professor Director, Cancer Center Clinica Mede Sacile


Japan

Naohito Yamaguchi, MD

Chief of Research Division, Saiseikai Research Institute of Health Care and Welfare Former Professor of Public Health, School of Medicine, Tokyo Women's Medical University


Kenya

Joseph Magero, BBA



Lithuania

Morgana Danielė

video on twitter

Malaysia

Dr Steven Chow

Quote Source / Bio and Photo


Dr Sharifa Ezat

  • Source
  • “If you smoke, stop. If you don’t smoke, don’t start. If you can’t stop, make the switch to a less harmful alternative.”

Dr Arifin Fii


Shamsul Bahri Mohd Tamrin, PhD

Professor of Occupational Safety and Health/Ergonomics Department of Environmental and Occupational Health University Putra Malaysia Shamsul Bahri Mohd Tamrin, PhD


Mexico

Ldo. Edgar Caballero

Behavioral psychologist



Dr. Jessica Esquivel Chahin

Doctor at the Institute of Minimally Invasive Thoracic Surgery at Hospital Ángeles Lomas. Expert in diagnosis and management of covid-19 patients. Health sciences teacher.



Dr. Jose Alejandro Chavez

Clinical Cardiologist. Member of the Medical Society of the General Hospital of Mexico. Member of the New York Academy of Sciences. USA. Member of the Mexican Society of Cardiology.



Christian Heinrich Henonin MD

MIPH International Public Health. Medical professor, researcher and health consultant Mexico



Dr. José Manuel Mier



Luz Odette Villegas Pichardo. MD

Internal Medicine. South Medical Hospital. Metropolitan Angeles Hospital.



Roberto A Sussman, PhD



Morocco

Imane Kendili MD



Netherlands (Holland)

New Zealand

PM Jacinda Ardern


Robert Beaglehole, MD, DSc

Robert: Bio and Photo / Follow Robert on Twitter

  • See Ruth Bonita

Ruth Bonita, MPH, PhD, MD (hon)


Julian Buchanan, CPA, DSW, MA, PhD



Chris Bullen, PhD


Marewa Glover, PhD



Deborah Hart LLB



Yolande Jeffares


George Laking, MD, PhD

Chair, End Smoking New Zealand

  • “Smokefree tobacco and nicotine products can displace smoking. Smoking combustible tobacco has the greatest of health burdens, so the point here is to reduce this, regardless of whether a product contains or doesn’t contain tobacco."


Dr Murray Laugesen

  • Follow on Twitter
  • “…inhaling mist from the e-cigarette is rated several orders of magnitude (100 to 1000 times) less dangerous than smoking tobacco cigarettes.”
  • Quote Source


Eliana Golberstein Rubashkyn, BSc Pharm, B. Chem



Dr Penelope Truman

Source of name

Natalie Walker, PhD

Associate Professor of Population Health and Director of the Centre for Addiction Research, National Institute for Health Innovation, Faculty of Medical and Health Sciences, University of Auckland


Ben Youdan

Source of name

Nigeria

ADEBISI Yusuff Adebayo

"Nicotine is not the primary cause of smoking-related diseases, including cancer."

Aishat Alaran

  • Follow on Twitter #WomenInTHR

MPhil Candidate at University of Cambridge. Commonwealth Shared Cambridge Trust Scholar. Public Health Researcher

Gabriel Oke

  • Quote Source
  • “Sweden’s success story revolves around the availability of a wide range of harm-reduction nicotine products such as Snus, nicotine pouches, and vaping. These alternatives have proven effective in helping smokers transition away from traditional cigarettes, thereby reducing their exposure to harmful toxins,”


Norway

Karl E Lund, PhD



Pakistan

Dr Ashar Ahmed

Source for name and quote

Dr. Ziauddin Islam

Quote Source / Photo and Bio / Follow on Twitter

  • "I wholeheartedly second Derek's opinion on ensuring easy access to alternative products for millions of tobacco consumers worldwide. Denying them these lifesaving options is, in my view, a cruel and criminal act."



Peru

Dr Omar Ghiglione

Venezuela, Peru Peripheral Vascular Surgeon.



Philippines

Dr. Rafael R. Castillo



Dr. Fernando Fernandez

Quote Source / Bio / Photo


Arleen R. Reyes, DMD, ICD, ICCDE

Past President, Philippine Dental Association Chairman, Commission on Dental Education Asia -Pacific Dental Federation Philippines


Ron Christian G. Sison, MLS(ASCPi), MPH

Assistant Professor Lead Convenor Harm Reduction Alliance of the Philippines Manila Philippines


Poland

Andrzej Sobczak, PhD

Professor Head of Department of General and Inorganic Chemistry Faculty of Pharmaceutical Sciences in Sosnowiec Medical University of Silesia Katowice Poland


Romania

Mihaela Răescu Phd



Scotland

Prof Linda Bauld, OBE



Dr. Ehsan Latif

  • Find quote


Christopher Russell, PhD



South Africa

Dr Kgosi Letlape



Solomon Rataemane



South Korea

Young-bum Park, PhD

Professor Department of Economics Hansung University South Korea


Spain

Manuel Linares Abad, PhD



José Mª García Basterrechea, MD

Associate Professor of Medicine University of Murcia Former head, Addiction and Dual Pathology Unit Reina Sofía Hospital. Spain.



Fernando Fernández Bueno, MD

Oncological surgeon at the Hospital Central de la Defensa Gómez Ulla Professor at the University of Alcalá de Henares Madrid Spain



Carmen Escrig, PhD



Miguel de la Guardia PhD

Professor of Analytical Cemistry University of Valencia Spain



Maria del Mar Sangüesa Jareño, MD

Intensive Care Specialist University Hospital of Ceuta, Spain



José David García Muñiz, MD, PhD

Clinical Pharmacology and Internal Medicine Clinical Trials Coordinator, Principal Investigator University Hospital of Ceuta Spain



Jose Miguel Rodriguez (Gonzalez-Moro)



Antonio Sierra, MD, PhD

Professor of Preventive Medicine and Public Health at the University of La Laguna. Former Dean of the Faculty of Medicine of the University of La Laguna Former General Director of Public Health of the Government of the Canary Islands



Francisco Garcia Sierra, MD.

Head of the Nephrology Service University Hospital of Ceuta Spain



Josep María Ramón Torrell, MD, PhD.

Professor of Epidemiology and Public Health University of Barcelona Head of Clinical Prevention Research Group Bellvitge Biomedical Research Institut Head of Tobacco Prevention Service Bellvitge Hospital Barcelona, Spain



Angel González Ureña, PhD

Emeritus Professor of Physical Chemistry. Complutense University of Madrid



Singapore

Tan Kok Kuan, MD

Medical Director Dr Tan Medical Center Novena Medical Center Singapore


Andrew John da Roza

Psychotherapist - Addictions Promises Health Care Pte. Ltd. Singapore


Sweden

Professor Tony Axéll

  • find quote


Curt Enzell


KARL FAGERSTRÖM PhD



Anders Milton MD, PhD

Quote Source / Bio and Photo


Lars Ramström PhD

Quote Source / Bio and Photo


Switzerland

Gizelle Baker



Jean-François Etter, PhD

Professor of public health Institute of Global Health, Faculty of Medicine University of Geneva


Moira Gilchrist PhD



Tikki Elka Pang, PhD

Former Director, Research Policy & Cooperation, WHO, Geneva Switzerland


Marina Suvakov

  • PMI


Tunisia

Fares Mili MD-CTTS- NCTTP

Quote Source: / Bio and Photo


United Arab Emirates

GOPAL BHATNAGAR, MD


Gopal Bhatnagar, MD, Chief of Cardiac Surgery, Heart and Vascular Institute, Cleveland Clinic, Abu Dhabi. Former Chief of Staff, Trillium Health Centre, Ontario, Canada. Vape Shop Owner: You just don’t victimize smokers twice. You don’t make something that’s hyper-addictive freely available to people and then you victimize them again by saying well you know there’s a technology that has the ability to help you get off this… but we’re going to restrict that.
Gopal Bhatnagar, MD, Chief of Cardiac Surgery, Heart and Vascular Institute, Cleveland Clinic, Abu Dhabi. Former Chief of Staff, Trillium Health Centre, Ontario, Canada. Vape Shop Owner.


Cother Hajat, MBBS PhD FFPH FRCP



United States

David Abrams PhD


David Abrams, PhD, Professor of Social and Behavioral Sciences, New York University School of Global Public Health: "E-cigarettes are substantially less harmful than burning toxic tobacco. They can help some people who have been unable to quit to switch and save their lives. The science in the last 2-3 years has become incredibly strong. It was the science that drove me to change my mind. I think we've forgotten it's the smoker and potential smoker we're supposed to be helping. They're people too. You can't forget that."
David Abrams, PhD, Professor of Social and Behavioral Sciences, New York University School of Global Public Health


Jerome Adams, MD, MPH



Jonathan H. Adler, JD


Jonathan H. Adler, JD Director, Coleman P. Burke Center for Environmental Law at Case Western Reserve University School of Law: "The reality, however, is that vaping products are far-less dangerous than combustible cigarettes, providing consumers with a safer way to consume nicotine and giving smokers a more effective means of quitting..."
Jonathan H. Adler, JD Director, Coleman P. Burke Center for Environmental Law at Case Western Reserve University School of Law


Jasjit S Ahluwalia, MD, MPH, MS



Bart Andrews, PhD

Bio and Photo / Quote Source / Follow on Twitter

Bart Andrews, PhD, Vice President, Telehealth and Home and Community Services, BHR: "Regardless of whether someone is predestined or not, some will use. That’s why harm reduction tools are incredibly important and why attempts to restrict or criminalize vaping increase harm."
Bart Andrews, PhD, Vice President, Telehealth and Home and Community Services, BHR


Tamar Antin, DrPH, MAA


Tamar Antin, DrPH, MAA, Director, Center for Critical Public Health: "...ignoring the potential benefits of harm reduction strategies may unintentionally lead to an erosion of trust in tobacco control among some members of the public.”
Tamar Antin, DrPH, MAA, Director, Center for Critical Public Health


Alex Azar, JD



David J. K. Balfour, DSc



Scott Ballin, JD


Scott D. Ballin, JD, Health Policy Consultant. Former VP and Legislative Counsel, American Heart Association. Former Chairman of the Coalition on Smoking OR Health (precursor to CTFK): "On the issue of flavorings, any concerns about flavoring and youth initiation should be balanced with ensuring that significantly lower risk products such as cigarettes are consumer acceptable to the millions of smokers looking to quit. This obviously involves flavorings and palatability. Nicotine replacement therapies (NRT) have long been available in a wide variety of flavors..."
Scott D. Ballin, JD, Health Policy Consultant. Former VP and Legislative Counsel, American Heart Association. Former Chairman of the Coalition on Smoking OR Health (precursor to CTFK).


Ronald Bayer, PhD


Ronald Bayer, PhD. Amy Fairchild, PhD, MPH: "Rejecting e-cigarettes because the tobacco industry will profit from them has the virtue of being uncompromising. But it also means rejecting the evidence and accepting the predictable, deadly toll of cigarette smoking. That’s a virtue, we argue, the world can no longer afford."
Ronald Bayer, PhD. Amy Fairchild, PhD, MPH.


Neal Benowitz



Aaron Biebert, BS


Aaron Biebert, BS, Award-winning documentary filmmaker. Former President, Clear Medical Solutions: "I believe it is a human right to have the accurate information needed to make personal health decisions about nicotine use as well as access to the safest nicotine-delivery system a person chooses without facing shame, stigma or “sin taxes.” There is a scientific consensus that nicotine vapor products are safer than cigarettes, so I believe they should be available and encouraged."
Aaron Biebert, BS, Award-winning documentary filmmaker. Former President, Clear Medical Solutions.


Chelsea Boyd



Professor Neil Boyd


Neil Boyd, Professor, School of Criminology, Simon Fraser University: "For current smokers, vaping is a much preferable alternative to combustion, and should not be discouraged, relative to the smoking of tobacco. Agree with restrictions on marketing to children."
Neil Boyd, Professor, School of Criminology, Simon Fraser University


Jeffrey Brandes



Thomas Brandon, PhD


Thomas Brandon, PhD Director, Moffitt Cancer Center, Tobacco Research and Intervention Program: "All of these studies, together with those from other labs, have informed my perspective that e-cigarettes represent the most important change in the landscape of tobacco use during my 36 years in this field. We need to harness this change to maximize the public health benefit from it."
Thomas Brandon, PhD Director, Moffitt Cancer Center, Tobacco Research and Intervention Program


Molly S. Brett, MD, Assistant Professor of Medicine, University of Colorado

  • Quote Source
  • "E-­cigarette use for smoking cessation remains controversial for some clinicians, in part because long­term health effects of e­-cigarettes are still unknown. Nevertheless, experts generally agree that e-­cigarettes are safer than continued use of conventional cigarettes, and I’ll continue to discuss the option of e-­cigarettes with my patients who have been unsuccessful with other smoking­ cessation methods."

Susan Cameron, MBA



Richard H Carmona MD, MPH, FACS



Representative Julie A. Casimiro



Azim Chowdhury, JD



Gal Cohen, PhD


Gal Cohen, PhD Head of Scientific Affairs, Rose Research Center Former Principal Scientist, JUUL Labs: "The reality we face as a society is that in spite of decades of concerted tobacco control initiatives and the efforts of the pharmaceutical industry, cigarettes are likely not going away soon. E-vapor products offer the most realistic opportunity to displace cigarette use in smokers who have not been able to quit with traditional methods. I predict that e-vapor products will ultimately be understood by the public health community as having a role when used responsibly as second-line harm reduction products for adult smokers."
Gal Cohen, PhD Head of Scientific Affairs, Rose Research Center Former Principal Scientist, JUUL Labs


Ari Cohn, JD


Ari Cohn, JD: "While vaping isn't totally safe (of course, no amount of car driving is totally safe either), it is certainly--on the whole--safer than smoking. And there's evidence that e-cigs are more effective at helping people quit smoking than other options"
Ari Cohn, JD


Suzanne M. Colby, PhD



James Colgrove, PhD, MPH


James Colgrove, PhD, MPH, Professor, Sociomedical Sciences, Columbia University Mailman School of Public Health: "Although some e-cigarette manufacturers have no links to the tobacco industry, Big Tobacco is consuming an ever-greater share of the e-cigarette market. It is hard for public health advocates like us to look favorably on anything the industry wants. But history shows that harm reduction — the doctrine that many risks cannot be eradicated and that efforts are best spent on minimizing the resulting harm — has had an important place in antismoking efforts and suggests that regulation is better than prohibition. If e-cigarettes can reduce, even slightly, the blight of six million tobacco-related deaths a year, trying to force them out of sight is counterproductive."
James Colgrove, PhD, MPH, Professor, Sociomedical Sciences, Columbia University Mailman School of Public Health


Kenneth Michael Cummings PhD, MPH



Brittani Cushman (TPB) spelling?

  • (Disclosure)



Cristine Delnevo, PhD, MPH, FAAHB



David Dobbins, JD, MPH



Clifford E. Douglas, J.D



David L. Eaton PhD


David L. Eaton, PhD, Department of Environmental and Occupational Health Sciences, School of Public Health, University of Washington: "Evidence suggests that while they're [e-cigarettes] not necessarily without health risks on their own, they are likely to be far less harmful than a conventional cigarette."
David L. Eaton, PhD, Department of Environmental and Occupational Health Sciences, School of Public Health, University of Washington


Allan Erickson



Michael Eriksen, ScD



Amy Fairchild, PhD, MPH


Ronald Bayer, PhD. Amy Fairchild, PhD, MPH: "Rejecting e-cigarettes because the tobacco industry will profit from them has the virtue of being uncompromising. But it also means rejecting the evidence and accepting the predictable, deadly toll of cigarette smoking. That’s a virtue, we argue, the world can no longer afford."
Ronald Bayer, PhD. Amy Fairchild, PhD, MPH.


David S. Fink, PhD, MPH


David S. Fink, PhD, MPH New York State Psychiatric Institute: "Tobacco is the leading cause of premature mortality, so let’s get people off tobacco then, that suggest we take UKs stance on this and move then to vaping, a unquestionably safer method of consumption..."
David S. Fink, PhD, MPH New York State Psychiatric Institute


Michael Fiore, MD, MPH, MBA


Michael Fiore, MD, MPH, MBA Founder & Director University of Wisconsin Center for Tobacco Research and Intervention:"Twenty individuals in Wisconsin are going to die prematurely [today] of a disease directly caused by their smoking, on average, robbing them of 10 to 15 years of life...vaping is, without a question, less dangerous than cigarette smoking."
Michael Fiore, MD, MPH, MBA Founder & Director University of Wisconsin Center for Tobacco Research and Intervention


Steve Forbes (Malcolm Stevenson Forbes Jr.)


Steve Forbes, Chairman and Editor-In-Chief, Forbes Media: "Vaping is actually very effective in helping people quit smoking... Attacking vaping with false information and distortions does a deadly disservice to public health."
Steve Forbes, Chairman and Editor-In-Chief, Forbes Media


Jonathan Foulds PhD



Tom Frieden, MD, MPH

  • Bio #1 / Photo and Bio #2 / Follow on Twitter / Quote source
  • Disclosure: Dr. Tom Frieden is President and CEO of Resolve to Save Lives (an initiative housed at Vital Strategies), launched in 2017 with support from Bloomberg Philanthropies, the Chan Zuckerberg Initiative, and the Bill and Melinda Gates Foundation. (Bloomberg Philanthropies is a funder of Vital Strategies.)


Tom Frieden, MD, MPH Director, Centers for Disease Control and Prevention (CDC) 2009 - 2017 Director, Global Health - Bloomberg Philanthropies 2006 - 2009: "For adults who use e-cigarettes and quit using conventional cigarettes completely and forever they [e-cigs] would be a benefit..."
Tom Frieden, MD, MPH Director, Centers for Disease Control and Prevention (CDC) 2009 - 2017 Director, Global Health - Bloomberg Philanthropies 2006 - 2009


Abigail S. Friedman PhD



Stephen F. Gambescia, PhD



Charles A. Gardner, PhD



Rob Gebelhoff, BA


Rob Gebelhoff Assistant Editor, The Washington Post: "If lawmakers insist on taxing e-cigarettes, fine. But then make sure that taxes for traditional tobacco products — including state and local taxes — remain considerably higher. Use the substitution effect to our advantage. The vaping industry is a tempting political target. But the proposed tax on its products is the wrong way to reduce the scourge of smoking."
Rob Gebelhoff Assistant Editor, The Washington Post


Karen K Gerlach, PhD, MPH



Joe Gitchell



Thomas J. Glynn, PhD

Adjunct Lecturer Prevention Research Center School of Medicine, Stanford University Formerly, Associate Director, Cancer Control Science Program, U.S. National Cancer Institute, and Director, Cancer Science and Trends, American Cancer Society



Will Godfrey

  • Founder Filter



Bill Godshall

Quote Source / Photo Source


Dr. Scott Gottlieb



Sharon H. Green, PhD, MPH


Sharon H. Green, PhD, MPH Postdoctoral Scholar University of California, Berkeley: "In England, where leading medical organizations regard nicotine alone as relatively benign, the pressing need to reduce the risks for current smokers frames the debate. The overwhelming focus in the United States is abstinence. In the end, the sorts of policies that are implemented will depend on whether whoever dominates the debate views harm reduction as opportunity or anathema."
Sharon H. Green, PhD, MPH Postdoctoral Scholar University of California, Berkeley


Marc Gunther



Jené Gutierrez, MA


Jené Gutierrez, MA, Journalist: "So here is my humble appeal to my fellow vape-judging brethren: Let’s admit that we were all wrong. Vaping, 95 percent healthier and 40 percent cheaper than smoking cigarettes, helps wean people off of an intense habit and naturally becomes an extension of their identity. So what? If this level of dedication to vaping is what destroys a dangerous addiction, then who cares? Looking down on vapers is basic and boring. They’re just doing the best they can, and are actually a less toxic presence because they vape—whether or not you want to admit it."
Jené Gutierrez, MA, Journalist


Scott Hadland, MD, MPH, MS, BS



Dorothy K. Hatsukami, PhD



Nan Hayworth, MD



Dr. Cheryl Healton

Founding President and CEO of American Legacy Foundation (created from MSA Funds, now known as the Truth Initiative); Dean of School of Global Public Health and Professor of Public Health Policy and Management, NYU School of Global Public Health; Founding chair of the Public Health Practice Council of the Association of Schools of Public Health; Serves on the National Board of Public Health Examiners, the Betty Ford Institute, Lung Cancer Alliance, Board of Directors at the Association of Schools and Programs of Public Health, and the Board of Directors at HealthRight International. Tobacco Harm Reduction Quote: E-cigarette Summit 2021 We treat addiction to combustible tobacco differently than addiction to other products with respect to harm reduction approaches. We are spending way too much time on infighting and too little time on finding common ground to massively reduce combustible tobacco use and ending the false equivalency between products. Smoking remains a worldwide tragedy causing a billion lives at stake in this century alone. Lower risk products exist to help those unable or unwilling to quit. We have abandoned our harm reduction approach in public health when it comes to saving smokers. Retirement from American Legacy (now Truth)

Amy Faith Ho, MD


Amy Faith Ho, MD: "Chained by practicality, physicians don’t have the luxury of shooting for the impossibility of no harm. It’s time for us to embrace, on all topics — sex, drugs, smoking, etc. — harm reduction."
Amy Faith Ho, MD


Matthew Holman, PhD



Chris Howard, JD



Angela Janis, MD, DFAPA



Matthew Wayne Johnson, Ph.D.



Senator Ron Johnson

  • Wisconsin



Peter Killeen PhD



Brian King

Jaron Hoani King


Bethea A Kleykamp, MA, PhD

  • Quote Source / Bio and Photo / Follow on Twitter
  • COI: I currently have no conflicts of interest with respect to tobacco, vaping or pharmaceutical industries. From May 2014 to September 2018, I provided harm reduction consulting services to an e-cigarette company (NJOY) and a tobacco company (RJ Reynolds) through my work at Pinney Associates.



Robin Koval



Lynn Kozlowski



Pritika Kumar R-Street

  • find quote


Ted Kyle, RPh, MBA



Jody Lanard MD



Harry A. Lando, PhD



Scott Leischow, PhD



Caryn Lerman, PhD



Alex Liber



Stefani Lord



Michael Madden, MD


Michael Madden, MD, Former Chief Medical Officer, Gateway Health: "No one wants a child to pick up an e-cigarette, but imprecise rhetoric about the reality of youth use of e-cigarettes misleads both the public and policymakers and results in tragic misunderstandings about one of the most promising tools public health has to help 34 million adults in this country who still smoke. Clear the air. Follow the science. Make tobacco harm reduction work for those who need it."
Michael Madden, MD, Former Chief Medical Officer, Gateway Health



Robin Mermelstein, Ph.D.

Distinguished Professor, Liberal Arts and Sciences Psychology Department Director, Institute for Health Research and Policy Co-Director, Center for Clinical and Translational Science University of Illinois at Chicago



Tom Miller JD




Ethan A Nadelmann


Ethan Nadelmann Founder, Drug Policy Alliance: “Cigarettes are truly deadly... if we can be moving people to a less harmful product, that’s what we should be doing... My fear is, that not only are we taking a major step backwards [in cutting rates of smoking], but we may be at the beginnings of the great new drug war of the 21st century.”
Ethan Nadelmann Founder, Drug Policy Alliance


Cam Nereim, MD, FAAP



Paul Newhouse

Quote source "It [nicotine] seems very safe even in nonsmokers. In our studies we find it actually reduces blood pressure chronically. And there were no addiction or withdrawal problems, and nobody started smoking cigarettes. The risk of addiction to nicotine alone is virtually nil."

Raymond S. Niaura, PhD


Raymond S. Niaura, PhD Professor of Social and Behavioral Sciences New York University School of Global Public Health Former Director, Science and Training, Schroeder Institute for Tobacco Research and Policy Studies at the Truth Initiative Former President of the Society for Research on Nicotine & Tobacco: "Tobacco control’s overarching goal is to save lives as rapidly and effectively as possible. This will require open minds to rethink harms of nicotine when it is decoupled from combustible tobacco. Ideally, to displace smoking, less harmful products would have to be as, or more, appealing. Regulations and policy initiatives should be aligned so that less harmful products are able to compete and replace smoking as the way to obtain and use nicotine."
Raymond S. Niaura, PhD Professor of Social and Behavioral Sciences New York University School of Global Public Health Former Director, Science and Training, Schroeder Institute for Tobacco Research and Policy Studies at the Truth Initiative Former President of the Society for Research on Nicotine & Tobacco


Joel Nitzkin, MD



Joe Nocera



Amy Nyman, MA



Michael Ogden, Phd



Cheryl K. Olson, Sc.D.



Jason Osborne



Laura Leigh Oyler



Amanda Palmer, PhD



Tommy J Payne, JD



Kenneth A. Perkins, PhD



Michael F. Pesko, PhD



Carl V. Phillips, MPP, PhD



Ovide Pomerleau, PHD



Helen Redmond, LCSW



Vaughan Rees, PhD



Nancy A. Rigotti, MD



Dr. Brad Rodu



Jed Rose (Title?)



Veronique de Rugy, PhD



Sally Satel


Sally Satel, MD: "...public-health institutions that promote harm-reduction strategies to users of other drugs, are reluctant, if not hostile, to extending the same forbearance to smokers. This paradox is rooted in the anti-tobacco movement, which has, along with irresponsible actions by public-health institutions, derailed the vaping revolution."
Sally Satel, MD


Steven A Schroeder, MD



John Seffrin, MD, PhD


John Seffrin, MD, PhD: "Technologies/alternatives exist today that can help people quit smoking or at least reduce significantly their consumption of burned tobacco, which is what kills them. After fighting the tobacco epidemic for over 5 decades, we now have proven harm reduction methods to help us avoid a carnage in otherwise preventable deaths."
John Seffrin, MD, PhD


Arielle Selya, PhD


Arielle Selya, PhD Scientist, Pinney Associates, Inc : "“Triangulating” across different types of research all support the story that e-cigarettes are displacing cigarettes."
Arielle Selya, PhD Scientist, Pinney Associates, Inc.


Michael Siegel

Visiting Professor, Department of Public Health and Community Medicine Tufts University School of Medicine Boston



Robert Sklaroff



Gary E. Swan, PhD



Maia Szalavitz


Maia Szalavitz, Award-winning neuroscience journalist: "Forcing people to quit often drives them underground, to more dangerous behavior, not less. Vaping is less harmful than smoking. If you try to eliminate harm, not reduce it, it can backfire."
Maia Szalavitz, Award-winning neuroscience journalist


Dr. Timothy Tolan, retired head and neck surgery otolaryngologist

  • Source
  • "Moving smokers away from cigarettes to less harmful alternative options like e-cigarettes will save millions of lives."

Benjamin Toll, PhD


Sheila Vakharia, PhD MSW



Dr. Timothy Vermillion

  • Photo and Bio / Quote Source
  • "Tactics and strategies that reduce the risks of inherently risky activities are core to military life. For service members and veterans who aren’t able or ready to quit nicotine, moving away from harmful cigarettes to a safer alternative is a logical step."

Harlan Vincent (NM)

  • find quote


Nora D Volkow, MD


Nora D Volkow, MD Director, National Institute on Drug Abuse (NIDA) at the National Institutes of Health: "...electronic cigarettes offer an alternative delivery for nicotine [for] people who cannot stop smoking. And in the process, the European data has shown that actually there are benefits."
Nora D Volkow, MD Director, National Institute on Drug Abuse (NIDA) at the National Institutes of Health


Carrie Wade, PhD



Sarah Elizabeth Wakeman, MD


Sarah Elizabeth Wakeman, MD Associate Professor of Medicine Harvard Medical School:"Rather than fear mongering and blanket vaping opposition how about we have smarter, more thoughtful regulation that doesn’t fall prey to Prohibitionist mindsets which encourage homemade, mason-jar crafted vaping liquids?"
Sarah Elizabeth Wakeman, MD Associate Professor of Medicine Harvard Medical School


Thomas J. Walters, MD


Thomas J. Walters, MD: "Other countries use vaped nicotine for smoking cessation. It's wise to learn from other cultures."
Thomas J. Walters, MD


Kenneth Warner, PhD



Craig Weiss, JD


Craig Weiss, JD, Former CEO NJOY: "If you make it just as inconvenient and expensive to smoke an electronic cigarette as a Marlboro, people are going to keep smoking Marlboros. Is that really the unintended consequence they want? To keep them smoking? Because that is what they are doing and we know the consequence of that is people are going to die a painful and early death."
Craig Weiss, JD, Former CEO NJOY


Daniel Wikler, Ph.D.

  • need to find quote



Derek Yach, MBChB, MPH, DSc



Claire Zagorski, MSc, LP



Mitch Zeller, JD

Bio / Photo Source / Quote Source


Venezuela

Dr Ali M Ayubi MD, MS, PhD.

Head of the Department of Behavioral Sciences and Addictions and Professor of Pharmacology, Behavioral Sciences and Addictions Medical University of the Caribbean Professor Emeritus of Pharmacology and Addiction Diseases of the University of Zulia.



Natasha A. de Herrera, PhD

Clinical Psychology, Centro Medico Docente la Trinidad, Psychiatric Unit, Smoking Cessation Clinic, Caracas



Statements by Multiple Parties

2021: One hundred specialists call for WHO to change its hostile stance on tobacco harm reduction - new letter to FCTC delegates published


2021: Reappraising Choice in Addiction: Novel Conceptualizations and Treatments for Tobacco Use Disorder


2021: 75 Tobacco Control experts ask CDC to change the name of EVALI


2019: Testimony for New York Senate hearing on vaping safety - Clive Bates and David Sweanor


2018: Letter from seventy-two specialists in nicotine science, policy and practice


????: Statement by 28 Medical Professionals in Latin America


Suggestions to add to this page

Dr Stuart Griffiths

  • Director of Research, Services and Policy at Yorkshire Cancer Research
  • "However, for stop smoking services to be successful in reducing the harm of tobacco they rely on the effective support of vaping products. Therefore, it is important not to discourage the use of vaping products for adults trying to quit smoking."

John T. Maier, Ph.D., MSW

Tackling Tobacco: Experts push for harm reduction strategies for smokers battling addiction

Lala Ashenberg Straussner, PhD, LCSW

NICOTINE POUCHES ARE GROWING IN POPULARITY. ARE THEY SAFE?

E-cigarettes found effective in smoking cessation. JEREMY FAUST, MD

Javier Nieto, nephrologist: "If smokers switch to smoke-free products they have less risk"

Simon Chapman

Dr. Vani Simmons

  • Source
  • “It does not mean that vaping is safe, but it does mean, in terms of the relative risks to combustible cigarettes, it is much safer and therefore represents a harm reduction product.”

What We Know (and Don’t) About Nicotine Pouches

World Vape Day: Expert urges global alignment on health policy for smokeless Nigeria

Op-ed: Former Alabama congressman says support less harmful smoking alternatives; save Black lives

Rep. Joshua Morris: Flavor ban wrong solution for tobacco cessation

Dr Kirstie Soar

2024: Employing tobacco harm reduction as a public health policy to drive down smoking rates in Nigeria, Ghana and Cameroon

2024: To Save Veterans’ Lives, the VA Must Innovate on Smoking Cessation

2023: Scientific Evidence Should Suggest a Middle Way

2023: Is vaping harmful to oral health?

2023: Joseph Nemeth, DDS

2023: Fight against addictions: parliament (finally) opts for scientific pragmatism!

  • Signatories:

Dr William Lowenstein, Addictologist President SoS Addiction Dr Imane Kendili, Addictologist Psychiatrist President of African Global Health Dr Alain Tolédano, Oncologist, radiotherapist, President of the Rafael Levallois-Perret Institute Dr Jean-Michel Delile, President of the Addiction Federation Marie Josée Augé-Caumon, pharmacist - co-partner of the Health-Addictions group, CESE report on tobacco and alcohol risk reduction, part of CAARUD Dr Jerôme Palazzolo, Psychiatrist Addictologist Nice Dr Hany Neamatalla, Cardiologist Paris Pompidou, Senator in Egypt Professor Gabriel Malka , Head of the Health Center at Mohammed VI University - Morocco Professor Chetty Morgan, Chairman of IPA-Foundation - USA Dr Jean-Pierre Couteron, Addictologist Paris Jean-Francois Narbonne , Toxicologist - Founder of the Food Toxicology Laboratory - Bordeaux University Dr Bertrand Lebeau Leibovici, Addictologist Jennifer Oses, Ecotoxicologist Dr Michael Bohbot , General Practitioner Dr Vittorio Bacchetta, General practitioner Professor Redouane Rabii, National Order Certified Urologist · Professor at the University of Medicine of Casablanca Dr Renaud David , Psychiatrist Dr Nathaniel Scher, Radiotherapist Oncologist Dr Pierre Guedj , Cardiologist Michael Stora , Psychoanalyst Professor Stéphane Mouly, Internal medicine Dr Pierre Rouzaud, tobacco specialist, Toulouse Professor Idrissi Hamza, Resuscitator Anesthetist Dr Serigne-Magueye Gueye, Professor of Urology at University Cheikh Anta DIOP, Dakar, Senegal and Chair of Urology, Director general of Campus Franco-Sénégalais Dr Benjelloun Faycal, Opthamologist

2023: Scientific Evidence Should Suggest a Middle Way

2021: SOVAPE 100+ doctors

Op-Ed | Tobacco policy in New York should help those looking for an alternative

Finland

Minister Duclos and Minister Bennett released a joint statement to mark National Non-Smoking Week

MUSC researching effects of e-cigarettes on cigarette smokers

Dr. Jan Nolta

  • ...if people switch to e-cigs instead of smoking, that’s a far better choice.

Britain must stand up to the WHO on vaping to save millions of lives

  • As Vice Chairs of the All-Party Parliamentary Group for Vaping in Westminster, we have both seen the benefits that vapes offer smokers, allowing them to move away from smoking-related diseases – and death - towards a less harmful alternative.
  • Tweet

E-cigarettes Volume 667: debated on Thursday 31 October 2019

India needs evidence-based harm reduction strategies: Dr. Peter Harper

MP Gareth Johnson

How bad is vaping and should it be banned?

Thai Committee on Public Health Suggests E-cigarette Regulation and to End Ban on Vaping

Swedish MEP Johan Nissinen: Sweden should do more for snus in the EU

Women power: researchers and experts who changed the THR field

Spain

It’s combustion in cigarettes that kills, not nicotine

See Letter: The benefits of vaping

CAPHRA Expert Advisory Group

Two from Canada

Delon Human

APTHRMedia – tobacco harm reduction archive

2022 LESS HARM: INTERNATIONAL DECLARATION FOR A SMOKE-FREE SPAIN

  • Signed by 170 experts

Doctors, scientists ask Marcos to sign vape bill

Maybe organization, too? SMOKING CESSATION: VAPE OR NOT VAPE?

2019 E-cigarettes need to be regulated, not banned: Dr Patrick Basham Read more at: https://health.economictimes.indiatimes.com/news/policy/e-cigarettes-need-to-be-regulated-not-banned-dr-patrick-basham/72392936

expert reaction to Department of Health press release ‘e-cigarettes could be prescribed on the NHS in world first’

E-cig Summit UK 2021 speakers

A New International Commission of Experts Finds the Global Fight Against Smoking Has Stalled

CRUCIAL STEP IN TOBACCO HARM REDUCTION

Canada

expert reaction to WHO report on nicotine and tobacco products

Ending Cigarette Use By Adults In A Generation Is Possible

Letter with names to research

More names to research for positive statements

Comments on vaping and tobacco harm reduction from expert stakeholders

More names on this doc

World No Tobacco Day: Here's why WHO’s approach to tobacco cessation needs an overhaul

The Truth Initiative, too, once embraced harm reduction. Its former board chairman, Tom Miller, Iowa’s long-serving attorney general, still argues that e-cigarettes are a “means to saving millions of lives.” Cheryl Healton, its former CEO, and David Abrams, formerly executive director of the Schroeder National Institute of Tobacco Research and Policy Studies, which is housed at the Truth Initiative, are harm-reduction advocates. So is Steven Schroeder, for whom the institute is named. Found here

72 Statements to WHO

M.O.V.E.

Quotes

Retrieved from "https://safernicotine.wiki/mediawiki/index.php?title=Nicotine_/_THR_-_Statements_from_Experts&oldid=76897"